These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12196332)

  • 1. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation.
    Achenbach S; Ropers D; Pohle K; Leber A; Thilo C; Knez A; Menendez T; Maeffert R; Kusus M; Regenfus M; Bickel A; Haberl R; Steinbeck G; Moshage W; Daniel WG
    Circulation; 2002 Aug; 106(9):1077-82. PubMed ID: 12196332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography.
    Hecht HS; Harman SM
    Am J Cardiol; 2003 Aug; 92(3):334-6. PubMed ID: 12888149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
    Callister TQ; Raggi P; Cooil B; Lippolis NJ; Russo DJ
    N Engl J Med; 1998 Dec; 339(27):1972-8. PubMed ID: 9869668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors.
    Pohle K; Mäffert R; Ropers D; Moshage W; Stilianakis N; Daniel WG; Achenbach S
    Circulation; 2001 Oct; 104(16):1927-32. PubMed ID: 11602496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
    Raggi P; Davidson M; Callister TQ; Welty FK; Bachmann GA; Hecht H; Rumberger JA
    Circulation; 2005 Jul; 112(4):563-71. PubMed ID: 16009795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
    Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
    JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography].
    Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.
    Wong ND; Kawakubo M; LaBree L; Azen SP; Xiang M; Detrano R
    Am J Cardiol; 2004 Aug; 94(4):431-6. PubMed ID: 15325924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
    Tardif JC; Grégoire J; L'Allier PL; Anderson TJ; Bertrand O; Reeves F; Title LM; Alfonso F; Schampaert E; Hassan A; McLain R; Pressler ML; Ibrahim R; Lespérance J; Blue J; Heinonen T; Rodés-Cabau J;
    Circulation; 2004 Nov; 110(21):3372-7. PubMed ID: 15533865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
    Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
    JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy.
    Raggi P; Callister TQ; Shaw LJ
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1272-7. PubMed ID: 15059806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Baumann D; Heuschmid M; Brodoefel H; Claussen CD; Kopp AF; Schroeder S
    Invest Radiol; 2007 Mar; 42(3):189-95. PubMed ID: 17287649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation by electron beam tomography of changes in calcified coronary plaque in treated and untreated asymptomatic patients and relation to serum lipid levels.
    Hecht HS; Harman SM
    Am J Cardiol; 2003 May; 91(9):1131-4. PubMed ID: 12714164
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management.
    Goh VK; Lau CP; Mohlenkamp S; Rumberger JA; Achenbach S; Budoff MJ
    Cardiovasc Ultrasound; 2010 Mar; 8():5. PubMed ID: 20226020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.
    Shin S; Park HB; Chang HJ; Arsanjani R; Min JK; Kim YJ; Lee BK; Choi JH; Hong GR; Chung N
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):437-446. PubMed ID: 27771404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
    Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
    J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipid modification on progression of coronary calcification.
    McCullough PA
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S115-9. PubMed ID: 16251246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
    Budoff MJ; Kessler P; Gao YL; Qunibi W; Moustafa M; Mao SS
    Acad Radiol; 2008 Jan; 15(1):58-61. PubMed ID: 18078907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.